HHealthcare Read More BioCryst is profitable. Now it wants to buy more rare disease drugsAugust 28, 2026 CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
HHealthcare Read More FDA approves Gilead HIV pill Bixlenvo designed to simplify treatmentAugust 28, 2026 Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
HHealthcare Read More The startup using AI to help build custom treatments for rare diseasesAugust 18, 2026 Jacalyn Lee, founder of The DAND Alliance, and her youngest daughter Isla. Jacalyn Lee CNBC Cures is proudly…
HHealthcare Read More Jazz Pharmaceuticals to buy Actio Biosciences for $820 millionAugust 13, 2026 Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…
BBusiness Read More Weight loss drug maker stock sinks 25% as safety data spooks investorsJune 8, 2026 Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
HHealthcare Read More AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of successJune 6, 2026 AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
MMedication Read More Reality of Trump’s drug pricing to set in over next 18 monthsApril 28, 2026 Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
HHealthcare Read More Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7BApril 20, 2026 Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
EEconomy Read More Trump tariffs fall, but trade war impacts lingerApril 3, 2026 A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
HHealthcare Read More Gilead to acquire cancer therapy developer ArcellxFebruary 23, 2026 A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…